中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2015年
11期
1648-1650
,共3页
伏志%王鑫%张媛媛%王璐%林栋栋
伏誌%王鑫%張媛媛%王璐%林棟棟
복지%왕흠%장원원%왕로%림동동
肝移植%精神异常%右美托咪定
肝移植%精神異常%右美託咪定
간이식%정신이상%우미탁미정
liver transplantation%Psychosis%Dexmedetomidine
目的:探讨右美托咪定对于预防肝移植术后早期精神异常的疗效及安全性。方法采用随机对照研究,将160例肝移植术后患者以抽签法随机分为两组各80例,分别应用右美托咪定治疗和咪达唑仑进行治疗组,比较两组患者的一般情况、精神异常发生率及不良反应发生情况。结果两组患者的的一般情况(性别、年龄、术后应用呼吸机时间、ICU 住院日、手术时间、术后 FK506血药浓度、术后24小时 APACHE II 评分)差异无统计学意义(P >0.05),术后精神异常发生率观察组20.00%,低于对照组38.75%(P =0.009),不良反应观察组低血压及高血压发生率高于对照组(P =0.035,P =0.029)。结论右美托咪定用于肝移植术后早期患者,可有效降低术后精神异常的发生。
目的:探討右美託咪定對于預防肝移植術後早期精神異常的療效及安全性。方法採用隨機對照研究,將160例肝移植術後患者以抽籤法隨機分為兩組各80例,分彆應用右美託咪定治療和咪達唑崙進行治療組,比較兩組患者的一般情況、精神異常髮生率及不良反應髮生情況。結果兩組患者的的一般情況(性彆、年齡、術後應用呼吸機時間、ICU 住院日、手術時間、術後 FK506血藥濃度、術後24小時 APACHE II 評分)差異無統計學意義(P >0.05),術後精神異常髮生率觀察組20.00%,低于對照組38.75%(P =0.009),不良反應觀察組低血壓及高血壓髮生率高于對照組(P =0.035,P =0.029)。結論右美託咪定用于肝移植術後早期患者,可有效降低術後精神異常的髮生。
목적:탐토우미탁미정대우예방간이식술후조기정신이상적료효급안전성。방법채용수궤대조연구,장160례간이식술후환자이추첨법수궤분위량조각80례,분별응용우미탁미정치료화미체서륜진행치료조,비교량조환자적일반정황、정신이상발생솔급불량반응발생정황。결과량조환자적적일반정황(성별、년령、술후응용호흡궤시간、ICU 주원일、수술시간、술후 FK506혈약농도、술후24소시 APACHE II 평분)차이무통계학의의(P >0.05),술후정신이상발생솔관찰조20.00%,저우대조조38.75%(P =0.009),불량반응관찰조저혈압급고혈압발생솔고우대조조(P =0.035,P =0.029)。결론우미탁미정용우간이식술후조기환자,가유효강저술후정신이상적발생。
Objective To investigate effects and safety of dexmedetomidine on the prevention of abnormal mental in patients after liver transplantation.Methods 160 patients after liver transplantation were randomly divided into the two groups using the drawing method:midazolam group(n =80),dexmedetomidine group(n =80),compared the two groups of patients with general,mental abnormality and the occurrence of adverse reactions.Results There were no significant differences in the general situation (gender,age,postoperative ventilator time,ICU stay time,oper-ation time,blood FK506 concentration,APACHEII score 24 hours after operation)of the two groups of patients (P >0.05),the spirit of the abnormal rate of the observation group was lower than that of the control group (P =0.009), incidence of hypotension and hypertension in the observation group was higher than that in the control group (P =0.035,0.029).Conclusion Dexmedetomidine can effectively reduce the postoperative mental disorders in patients in the early stage after liver transplantation.